New Potomac Partners’s Medtronic MDT Stock Holding History

New Potomac Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-83	Closed	-$7K	–	146
2018 Q2	$7K	Hold	83	–	–	0.01%	138
2018 Q1	$7K	Hold	83	–	–	0.01%	139
2017 Q4	$7K	Buy	+83	New	+$6.65K	0.01%	138

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

New Potomac Partners's MDT Position: Q3 2018 in Review

New Potomac Partners sold out of Medtronic (MDT) in Q3 2018, closing a stake of 83 shares — an estimated $7K sold.

New Potomac Partners first reported a position in MDT in Q4 2017 and held it in 3 quarters. The position peaked at $7K in Q2 2018. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

New Potomac Partners reported no remaining Medtronic position as of Q3 2018 after selling out during the quarter.
New Potomac Partners sold 83 Medtronic shares in Q3 2018, an estimated $7K.
New Potomac Partners first reported a position in Medtronic in Q4 2017 and held it in 3 quarters.
New Potomac Partners's Medtronic position peaked at $7K in Q2 2018.
1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on New Potomac Partners's 13F filing for Q3 2018, filed 23 Oct 2018.